In conclusion, our current study revealed that Th17 cell/IL-17A is critical in the fight against PmA and that the IL-6–Jak2–Stat3 axis promoted Th17 cell/IL-17A activation during PmA infection in vivo. Here, IL17A is linked to pilomyxoid astrocytoma.